Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons

被引:194
作者
Hajjeh, RA
Conn, LA
Stephens, DS
Baughman, W
Hamill, R
Graviss, E
Pappas, PG
Thomas, C
Reingold, A
Rothrock, G
Hutwagner, LC
Schuchat, A
Brandt, ME
Pinner, RW
机构
[1] Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Mycot Dis Branch, Atlanta, GA 30333 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Vet Affairs Med Ctr, Atlanta, GA 30033 USA
[4] Baylor Coll Med, Houston, TX 77030 USA
[5] Univ Alabama, Birmingham, AL USA
[6] Univ Calif Berkeley, Berkeley, CA 94720 USA
关键词
D O I
10.1086/314606
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the incidence of cryptococcosis and its risk factors among human immunodeficiency virus (HIV)-infected persons, population-based active surveillance was conducted in four US areas (population, 12.5 million) during 1992-1994, and a case-control study was done. Of 1083 cases, 931 (86%) occurred in HIV-infected persons, The annual incidence of cryptococcosis per 1000 among persons living with AIDS ranged from 17 (San Francisco, 1994) to 66 (Atlanta, 1992) and decreased significantly in these cities during 1992-1994, Among non-HIV-infected persons, the annual incidence of cryptococcosis ranged from 0.2 to 0.9/100,000. Multivariate analysis of the case-control study (158 cases and 423 controls) revealed smoking and outdoor occupations to be significantly associated with an increased risk of cryptococcosis; receiving fluconazole within 3 months before enrollment was associated with a decreased risk for cryptococcosis. Further studies are needed to better describe persons with AIDS currently developing cryptococcosis in the era of highly active antiretroviral therapy.
引用
收藏
页码:449 / 454
页数:6
相关论文
共 19 条
[1]   Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States [J].
Brandt, ME ;
Hutwagner, LC ;
Klug, LA ;
Baughman, WS ;
Rimland, D ;
Graviss, EA ;
Hamill, RJ ;
Thomas, C ;
Pappas, PG ;
Reingold, AL ;
Pinner, RW ;
Stephens, D ;
Farley, M ;
Bardsley, M ;
Siegel, B ;
Jackson, G ;
Lao, C ;
Otte, J ;
Harvey, C ;
Gillespie, R ;
Rothrock, G ;
Pattni, B ;
Daily, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :912-917
[2]  
CASTRO KG, 1988, 28 INT C ANT AG CHEM
[3]  
*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P165
[4]  
DROMER F, 1992, J MED VET MYCOL, V30, P395
[5]   CRYPTOCOCCAL MENINGITIS AFTER UNUSUAL EXPOSURES TO BIRDS [J].
FESSEL, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (18) :1354-1355
[6]   Tobacco smoke as a risk factor for meningococcal disease [J].
Fischer, M ;
Hedberg, K ;
Cardosi, P ;
Plikaytis, BD ;
Hoesly, FC ;
Steingart, KR ;
Bell, TA ;
Fleming, DW ;
Wenger, JD ;
Perkins, BA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (10) :979-983
[7]   Emergence of cryptococcal disease: Epidemiologic perspectives 100 years after its discovery [J].
Hajjeh, RA ;
Brandt, ME ;
Pinner, RW .
EPIDEMIOLOGIC REVIEWS, 1995, 17 (02) :303-320
[8]   EPIDEMIOLOGIC DIFFERENCES BETWEEN THE 2 VARIETIES OF CRYPTOCOCCUS-NEOFORMANS [J].
KWONCHUNG, KJ ;
BENNETT, JE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1984, 120 (01) :123-130
[9]   OCCURRENCE OF CRYPTOCOCCUS NEOFORMANS IN ENVIRONMENT OF 3 GEOGRAPHICALLY ASSOCIATED CASES OF CRYPTOCOCCAL MENINGITIS [J].
MUCHMORE, HG ;
NIX, GE ;
FELTON, FG ;
CARPENTER, RE ;
RHOADES, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1963, 268 (20) :1112-&
[10]  
PINNER RW, 1991, 31 INT C ANT AG CHEM